KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Synopsys (SNPS) over the last 8 years, with Q4 2025 value amounting to -$11.6 million.

  • Synopsys' Change in Inventory rose 4182.03% to -$11.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $22.5 million, marking a year-over-year decrease of 5623.43%. This contributed to the annual value of $22.5 million for FY2025, which is 5623.43% down from last year.
  • As of Q4 2025, Synopsys' Change in Inventory stood at -$11.6 million, which was up 4182.03% from -$5.7 million recorded in Q3 2025.
  • Synopsys' Change in Inventory's 5-year high stood at $60.9 million during Q1 2024, with a 5-year trough of -$19.9 million in Q4 2024.
  • In the last 5 years, Synopsys' Change in Inventory had a median value of $4.5 million in 2022 and averaged $12.2 million.
  • In the last 5 years, Synopsys' Change in Inventory surged by 391306.16% in 2023 and then tumbled by 430712.33% in 2025.
  • Synopsys' Change in Inventory (Quarter) stood at -$3.4 million in 2021, then soared by 64.67% to -$1.2 million in 2022, then surged by 3913.06% to $45.8 million in 2023, then plummeted by 143.32% to -$19.9 million in 2024, then skyrocketed by 41.82% to -$11.6 million in 2025.
  • Its Change in Inventory stands at -$11.6 million for Q4 2025, versus -$5.7 million for Q3 2025 and -$16.1 million for Q2 2025.